News

Press Release
RepliCel Life Sciences Joins Centre for Commercialization of Regenerative Medicine, Industry Consortium
CCRM and RepliCel to Partner on Development of Cell Therapies for Tendon Repair VANCOUVER, BC...
Press Release
RepliCel Announces 2014 Second Quarter Financial Results
VANCOUVER, BC – August 26, 2014 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)(TSXV:RP)...
As Seen In
August 7, 2014 – Mark Landy from Summer Street Research Partners Comments on RepliCel in August’s issues of The Life Sciences Report
To read the full report click here: Mark Landy on New Growth Ideas for Biotech...
Press Release
RepliCel Appoints Brooke Hurford as Corporate Secretary and Director, Finance
VANCOUVER, BC – July 16, 2014 – RepliCel Life Sciences Inc. (the “Company”) (TSXV: RP)...
As Seen In
BioWatch News – RepliCel as a Featured Company in June’s Issue Exploring Alopecia and its Industry
Cell therapies for curing alopecia are early in their clinical development. These must still show...
As Seen In
July 10, 2014 – Alan Leong from BioWatch News Comments on RepliCel in July’s Issues of The Life Sciences Report
For the full article click here: Alan Leong Interview on Niche Biotech Prospects life-scineces-report Read...
Press Release
RepliCel Retains O&M Partners to Coordinate North American Focused Investor Marketing Campaign
VANCOUVER, BC – June 20, 2014 – RepliCel Life Sciences Inc. (TSXV: RP) (OTCQB: REPCF),...
As Seen In
Yahoo Sports Article – RepliCel interviewed on Cristiano Ronaldo’s obscure injury could open door for U.S.
By Martin Rogers June 8, 2014 11:14 PM Yahoo Sports SAO PAULO – To a...
Press Release
RepliCel Life Sciences Announces Closing of Third and Final Tranche of Private Placement
VANCOUVER, BC – June 17, 2014 – RepliCel Life Sciences Inc. (“RepliCel” or the “Company”)...
Press Release
RepliCel Retains Christina Cameron as Canadian Investor Relations Consultant
VANCOUVER, BC – June 5, 2014 – RepliCel Life Sciences Inc. (TSXV: RP) (OTCQB: REPCF),...
As Seen In
Cell Therapy Group Interview with CEO, David Hall
Despite us both living in the Vancouver area and both being involved in cell therapy,...
Press Release
RepliCel Life Sciences Inc. Announces Closing of Second Tranche of Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES ORDISSEMINATION IN OR INTO THE UNITED STATES...
Press Release
RepliCel Life Sciences’ Licensing Partner, Shiseido, Opens Cell Processing and Expansion Facility in Japan to Advance RCH-01, a Treatment for Pattern Baldness
VANCOUVER, BC – May 20, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP)...
Press Release
RepliCel Life Sciences Inc. Announces Closing of Brokered and Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES ORDISSEMINATION IN OR INTO THE UNITED STATES...
Press Release
RepliCel Life Sciences Announces Brokered Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED...
Press Release
RepliCel Reports 2013 Annual Financial Results
VANCOUVER, BC – March 18, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP)...
Events
RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress of the Japanese Society for Regenerative Medicine
VANCOUVER, BC – February 27, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP)...
As Seen In
RepliCel Life Sciences Inc. (TSXV: RP) Seeks to Heal with Patients Own Cells
 FINANCIAL POST ARTICLE PUBLISHED ON FEBRUARY 25, 2014Imagine using healthy cells from your body to...
Press Release
RepliCel Retains Ubika Communication for Online Capital Market Exposure
VANCOUVER, BC – February 26, 2014 – RepliCel Life Sciences Inc. (TSXV: RP) (OTCQB: REPCF),...
Press Release
RepliCel Receives Japanese Patent Covering its Hair Regeneration Technology
VANCOUVER, BC – January 13, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP)...

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.